Correction: Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis
Ha Thi Nguyen, Vishnu Nayak Badavath, Siddhartha Maji, Haritha Polimati, Emmanuel Okello, Richard A. Bunce, Nguyen Huy Thuan, Wan Mohd Nuzul Hakimi Wan Salleh, Vinay Bharadwaj Tatipamula
TL;DR
This paper corrects a previous study on natural compounds from a lichen that may help fight drug-resistant tuberculosis.
Contribution
The paper provides corrections to prior research on the potential of Lobaria pulmonaria metabolites against tuberculosis.
Findings
The original study's findings on enzyme-targeting metabolites are being corrected.
The corrections address errors in the prior research on multidrug-resistant tuberculosis strategies.
Abstract
Correction for ‘Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis’ by Ha Thi Nguyen et al., RSC Adv., 2026, 16, 8960–8970, https://doi.org/10.1039/D5RA05774D.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSesquiterpenes and Asteraceae Studies · Natural product bioactivities and synthesis · Plant chemical constituents analysis
The authors regret that several errors were introduced into the affiliations section of the published manuscript. The corrected affiliations are as shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.